Bioprosthetic heart valves: The last taboo - clinical evidence, ethico-legal assessments and informed consent in Muslim patients
World Journal of Cardiology · 26.06.2026 · 18 (6)
DOI: 10.4330/wjc.121917 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Cardiology, online erschienen am 26.06.2026. Verfasst von Mohamed Bamoshmoosh und 8 weiteren Autor:innen. Die Arbeit nennt 56 Literaturangaben.
Abstract (Originalsprache)
The recent 2025 European Society of Cardiology (ESC)/European Association for Cardio-Thoracic Surgery (EACTS) guidelines for the management of valvular heart disease (VHD) state that treatment should be tailored to patient’s preferences. Durability is the main limitation of bioprosthetic heart valves (BHVs), due to structural valve degeneration and increased pannus formation. There is no definitive evidence that bovine pericardium protheses (BPP) are inferior to porcine xenografts (PX) in terms of durability. Muslim patients, due to their religious belief, may prefer to be treated with BPP rather than PX, except for Darurah (emergency) and Istihalah (physicochemical transmutation) conditions. Our paper highlights two key point. First, Italian Muslim professionals have little information concerning the presence of porcine derivatives in BHVs and regarding the existence of an alternative to PX with BPP. Second, the quality and quantity of biological material in BHVs is only known by bio-manufacturers that do not disclose this data spontaneously. To comply with the 2025 ESC/EACTS guidelines for the management of VHD, we believe that the heart team could benefit from the advice of qualified Islamic religious leaders in delivering to Muslim patients the scenario of BHV utilization with complete, relevant, and accessible information.
Zitieren
APA
Bamoshmoosh, M., Afifeh, A. M. S., Sharkawy, Y. E., Dahir, F. Z., Chebab, A., Tarakji, H., Sbai, Y., Ouafiq, A., & Hussein, A. (2026). Bioprosthetic heart valves: The last taboo - clinical evidence, ethico-legal assessments and informed consent in Muslim patients. World Journal of Cardiology, 18(6). https://doi.org/10.4330/wjc.121917
Vancouver
Bamoshmoosh M, Afifeh AMS, Sharkawy YE, Dahir FZ, Chebab A, Tarakji H, et al. Bioprosthetic heart valves: The last taboo - clinical evidence, ethico-legal assessments and informed consent in Muslim patients. World Journal of Cardiology. 2026;18(6). doi:10.4330/wjc.121917
BibTeX
@article{Bamoshmoosh2026,
author = {Bamoshmoosh, Mohamed and Afifeh, Arraa Maddalena Saghir and Sharkawy, Younes El and Dahir, Fatima Zahra and Chebab, Ahmed and Tarakji, Humam and Sbai, Yasmin and Ouafiq, Ahlam and Hussein, Amr},
title = {Bioprosthetic heart valves: The last taboo - clinical evidence, ethico-legal assessments and informed consent in Muslim patients},
journal = {World Journal of Cardiology},
year = {2026},
volume = {18},
number = {6},
doi = {10.4330/wjc.121917}
}
EUVIMED